Best Unlisted Shares to Buy in India 2026: Screened & Ranked
08 June 2026 · Sachin Gadekar
A fundamentals-first screening of the most discussed unlisted shares in India in 2026 -covering NSE, NSDL, CSK, Zepto, OYO, Hero Fincorp, and others ranked by business quality, valuation risk, and realistic IPO outlook, with the HDB Financial lesson applied throughout.

Before looking at any list of unlisted shares to buy in 2026, one event from 2025 deserves your full attention.
HDB Financial Services -one of the most discussed and widely held unlisted shares in India -traded in the unlisted market at approximately ₹1,200–₹1,250 per share in the months before its IPO. Investors bought at those prices expecting significant listing gains. The IPO was priced at ₹740 -a 40% discount to the unlisted market price. The stock listed at ₹835 -still 33% below what unlisted investors had paid. As of early 2026, HDB Financial trades around ₹652–₹765 on the exchanges.
Investors who bought HDB Financial in the unlisted market at ₹1,200 have lost approximately 40–45% of their capital -not because the business was bad, but because the unlisted market price was untethered from fundamental valuation. They were paying an IPO-hype premium that the actual IPO priced never validated.
Analysts highlighted that investor behaviour in the unlisted space is often driven by FOMO (fear of missing out), with fundamentals frequently overlooked.
This article is the antidote to that approach. Every company on this list is screened against three questions before ranking: Is the business fundamentally sound? Is the current unlisted price reasonable relative to listed peers? And what does the realistic IPO timeline and exit look like?
The HDB Financial Lesson: Why Unlisted Price ≠ Fair Value
The HDB Financial Services story is the most important case study in unlisted market investing in recent years -and it happened in 2025, making it directly relevant to 2026 decisions.
The timeline:
HDB Financial unlisted price: ~₹1,200–₹1,250 (pre-IPO)
IPO issue price: ₹740 (40% below unlisted market price)
IPO listing: ₹835 (12.8% above IPO price, but 33% below unlisted purchase price)
Current trading (early 2026): ~₹652–₹765
What went wrong for unlisted investors: The unlisted market had priced HDB Financial at valuations that the actual IPO process -with investment bankers, institutional book-building, and market validation -did not support. Unlisted investors were paying a premium that assumed an IPO at or above unlisted prices. When the IPO came at ₹740, the market was essentially telling unlisted holders their assessment was wrong.
The structural problem: Unlisted share prices are set by supply and demand in an opaque, thin market -not by fundamental analysis or institutional validation. When demand is high (lots of retail FOMO, positive news cycle), unlisted prices can run far above what the business actually justifies. This is the primary risk in unlisted investing.
The lesson: Always compare the unlisted price to what the same business would be worth if it were listed today -using comparable listed companies' P/E or P/B multiples. If the unlisted price implies a valuation materially above listed peers without a compelling reason, the premium is risk, not return.
The Screening Framework: How We Ranked These Companies
Every company in this list is scored on four dimensions:
1. Business quality: Is the underlying business genuinely strong -growing revenues, positive or improving profitability, durable competitive advantage, management track record?
2. Valuation sanity: Does the current unlisted price imply a reasonable valuation when compared to listed peers? Is the premium to listed comparables justified?
3. IPO visibility: Is there a realistic, near-term path to listing that provides an exit? SEBI approvals filed? Investment bankers appointed? DRHP submitted?
4. Downside protection: What is the floor? If the IPO is delayed or priced below current unlisted market price, what is the realistic downside?
Companies are ranked with the HDB Financial lesson explicitly in mind -a high ranking requires both business quality AND valuation discipline.
Rank 1: NSE (National Stock Exchange of India)
Why it ranks first: NSE is the most fundamentally strong unlisted company in India. It is India's largest stock exchange by trading volume -running the world's largest derivatives market by number of contracts. It has a dominant market position, exceptional profitability, and a business model that generates recurring revenue from every trade executed on India's financial markets.
The business case:
NSE handles approximately 90% of India's equity derivatives trading
Revenues are driven by transaction fees, listing fees, data services, and indices licensing
Profitability is exceptionally high -a near-monopoly exchange structure with minimal marginal cost
Comparable listed peers: BSE (listed), CDSL (listed), MCX (listed)
The valuation framework: At ~₹2,000–₹2,100 per share, NSE trades at a significant premium to BSE's listed valuation on a P/E basis. BSE trades at approximately 60–70x earnings (elevated, but exchange stocks command premium multiples). NSE's earnings are substantially higher than BSE -the valuation comparison must be done on absolute profit level, not just multiple.
2026 IPO update: NSE has kick-started its long-awaited IPO process by inviting bankers for a ~$2.5 billion pure OFS issue. This is the most significant development -active banker appointment signals a genuine IPO push rather than indefinite delay.
The honest risk: NSE has been "about to IPO" for years. Regulatory hurdles (the co-location controversy, SEBI scrutiny) previously blocked the process. The current IPO push is real but regulatory clearances remain the key variable.
Investment view: NSE is a high-quality business worth owning. The critical discipline is price -do not pay above the valuation implied by BSE and MCX multiples applied to NSE's earnings. At current unlisted prices of ₹2,000–₹2,100, run the valuation comparison carefully before investing.
Rank 2: NSDL (National Securities Depository Limited)
Why it ranks second: NSDL is India's oldest and largest depository -holding 93%+ of the value of securities held in demat form in India. Every stock, bond, and mutual fund unit held in demat exists in either NSDL or CDSL. This is infrastructure-level monopolistic positioning in India's financial system.
The business case:
NSDL processes settlement for virtually all significant institutional and HNI holdings
Revenue from account maintenance charges, transaction fees, and KYC services
Listed comparable: CDSL (Central Depository Services) -trades on BSE/NSE and provides a direct valuation benchmark
The valuation framework: CDSL trades at approximately 55–65x earnings (as of 2026). NSDL's unlisted price of ~₹1,000–₹1,100 should be benchmarked against what multiple this implies versus NSDL's reported earnings. NSDL saw its unlisted shares fall by nearly 21 per cent -from Rs 1,275 to Rs 1,025 -attributed to uncertainty around the IPO timeline. This correction has improved the entry point meaningfully versus the peak.
2026 IPO status: SEBI had granted in-principle approval for NSDL's IPO. The timeline has faced extensions -SEBI's original approval deadline of April 2024 was extended to July 2025. Current status requires verification of whether further extensions have been granted. This timeline uncertainty is the primary risk.
Investment view: Strong business, corrected price -but IPO timeline uncertainty is real. Suitable for investors with a 2–4 year holding horizon who can accept the possibility of further delays.
Rank 3: Hero Fincorp
Why it ranks third: Hero Fincorp is the financial services arm of the Hero Group -one of India's largest auto conglomerates. It primarily provides two-wheeler loans, personal loans, and MSME credit, with a strong distribution network leveraging Hero MotoCorp's dealer ecosystem.
The business case:
Strong parentage -Hero Group brand and distribution network
Two-wheeler financing is a large, growing market in India
~₹1,050 current unlisted price represents a correction from earlier highs (was ~₹1,600–₹1,700 peak)
Valuation benchmark: Compare to listed peers: Cholamandalam Investment & Finance (vehicle financing focused), Bajaj Finance (diversified NBFC), HDFC Bank (parent category). Tata Capital shares declined around 14 percent following a steep-discount rights issue -this peer group dynamic should be considered when evaluating NBFC unlisted valuations broadly.
IPO visibility: Hero Fincorp has discussed IPO plans but no DRHP has been filed as of mid-2026. The timeline is unclear -possibly 12–24 months.
Investment view: Good business at a more reasonable price after correction. The longer IPO timeline and NBFC sector headwinds (RBI regulatory tightening on NBFC-UL entities) make this a patient investor's holding.
Rank 4: Cochin International Airport (CIAL)
Why it ranks fourth: CIAL is India's first public-private partnership airport and the world's first fully solar-powered international airport. It serves Kerala's significant NRI traveller base and the state's growing tourism sector. Revenue is primarily from aeronautical services (landing fees, terminal charges) and non-aeronautical (retail, F&B, parking).
The business case:
Infrastructure monopoly -Cochin's primary international airport
Steady, recurring revenue from air traffic that correlates with Kerala's NRI remittances and tourism
Low technology obsolescence risk versus financial or tech sector unlisted companies
Valuation benchmark: Listed airport comparables in India include Adani Airports (delisted from separate entity; now within Adani Enterprises) and Delhi/Mumbai airports (GMR Airports Infrastructure, MIAL). Airport businesses typically trade at EV/EBITDA multiples of 15–25x.
IPO visibility: No confirmed IPO plans for CIAL as of 2026. This is a long-hold investment without a clear near-term exit. Suitable for investors who want infrastructure exposure with patient capital.
Investment view: High-quality infrastructure asset. Not a near-term IPO play -this is a long-duration hold (3–7 years) for investors comfortable with illiquid infras
Rank 5: CSK (Chennai Super Kings Cricket Ltd)
Why it ranks fifth: CSK is one of India's most successful and profitable IPL franchises -5-time IPL champions, one of the largest and most loyal fan bases, and a brand that commands significant commercial revenue from media rights, merchandise, and sponsorships.
The business case:
IPL media rights value has grown dramatically -Star India and JioCinema pay significantly for broadcast rights
CSK generates revenue from player salary caps (team performance efficiency), commercial sponsorships, and franchise fee sharing
Unlike most sports franchises globally, CSK generates consistent operating profits
The valuation challenge: Sports franchise valuation is inherently speculative. There are no standard P/E or P/B multiples that apply -valuation depends on brand value, future media rights escalation, and the IPO market appetite for an entertainment/sports stock. At ~₹250–₹260 per share, the implied market cap and what multiple it represents of CSK's earnings requires careful analysis.
IPO visibility: No confirmed IPO timeline as of 2026.
Investment view: Interesting as a brand play on India's cricket economy. But purely speculative from a valuation standpoint -there is no reliable way to anchor the "right price" for an IPL franchise. Buy only with full awareness that this is sentiment and brand-driven, not fundamental.
Rank 6: Zepto
Why it ranks sixth: Zepto is India's fastest-growing quick commerce platform -10-minute grocery delivery with dark store infrastructure across India's major metros. It competes with Blinkit (Zomato) and Swiggy Instamart in a sector that has seen explosive growth.
The business case:
Quick commerce is a genuinely large and growing market in India
Zepto has demonstrated strong execution -rapid dark store expansion, improving unit economics
Pre-IPO funding rounds at increasing valuations indicate institutional conviction
The risk reality: Zepto is still burning cash to fund growth. The path to profitability is visible but not confirmed. In a startup investment, the quality of the business model and management matters enormously -and cannot be verified from public financials the way a listed company can be.
Unlisted price at ~₹58 suggests a certain valuation -but without audited financials and a clear P/E anchor, the "right" unlisted price is impossible to verify independently.
Investment view: High-risk, high-potential. For investors with 3–5 year horizon and comfort with startup risk. Maximum allocation: small satellite position, not a core portfolio holding.
Rank 7: OYO (Oravel Stays / PRISM)
Why it ranks seventh: OYO is one of India's most globally known startups -a hospitality technology company that aggregates budget hotels under a standardised brand. It has improved significantly from its peak-crisis days (2022–23) with revenue recovery and losses narrowing.
Why it ranks below others: OYO has attempted and withdrawn IPO filings multiple times -the regulatory and market conditions have repeatedly forced plan changes. IPO-bound PRISM, the parent of OYO, has appointed former Securities and Exchange Board of India (SEBI) chairman Ajay Tyagi as a board advisor -a positive governance signal, but the IPO timeline remains uncertain.
Investment view: The business has improved but the history of restructuring, promoter-level complexity, and repeated IPO delays make this a higher-risk position than its headline name suggests. Only for investors who have studied the business deeply and accept high uncertainty on exit timing and price.
Companies to Approach With Caution in 2026
Some widely discussed unlisted names deserve explicit caution flags:
PharmEasy (API Holdings): Significant financial distress -the company has undergone major debt restructuring after its IPO was withdrawn. The unlisted price (which has collapsed dramatically from peak) reflects genuine business and financial risk. Not a safe unlisted investment in 2026.
Any company with "great GMP, must buy" narrative: The grey market premium (GMP) predicts short-term listing pop -not long-term value. HDB Financial had a positive GMP before listing below unlisted market prices. GMP is noise; fundamentals are signal.
Companies where unlisted price has surged on IPO rumours alone: If the unlisted price has moved primarily because of news that an IPO is being planned -not because of improving business fundamentals -the risk profile is identical to HDB Financial pre-IPO. Exit-driven unlisted investing at elevated prices is where most unlisted market losses happen.
FAQs
Q1. What are the best unlisted shares to buy in India in 2026?
Based on fundamental quality, reasonable valuation, and IPO visibility: NSE (India's largest exchange, active IPO process underway) and NSDL (leading depository, price corrected from peak) rank highest for business quality and plausible exit. Hero Fincorp and CIAL offer good fundamental quality with longer hold timelines. CSK, Zepto, and OYO are speculative plays suitable only for investors with high risk tolerance and long horizons.
Q2. Are unlisted shares a good investment in India in 2026?
They can be -if bought at reasonable valuations with a 3–5 year horizon. The HDB Financial lesson (bought at ₹1,250 unlisted, IPO at ₹740, now trading ~₹700) is the 2025 reminder that unlisted market prices often run ahead of fundamental value. The key discipline is valuation -always compare unlisted price to listed peer multiples before buying.
Q3. How do I buy unlisted shares in India?
Through SEBI-regulated platforms and established OTC dealers (Planify, UnlistedZone, Precize, InCred Money). Payment via bank transfer, shares credited to your demat account within 24–48 hours. Always verify the price across multiple platforms and do independent valuation work before investing.
Q4. What is the tax rate on unlisted shares in India?
Gains on unlisted shares held more than 24 months are taxed at 12.5% LTCG (no indexation, post-Budget 2024). Gains on shares held less than 24 months are taxed at slab rate (up to 42.74% for ultra-HNIs). This is a critical planning point -if you buy unlisted shares and the company lists within 24 months of your purchase and you sell on listing, STCG at slab rate applies.
Q5. What is the NSE unlisted share price in 2026?
NSE unlisted shares trade at approximately ₹2,000–₹2,100 per share in the OTC market as of mid-2026. Prices vary between platforms and update based on recent transactions. NSE has initiated its IPO process by appointing bankers for a ~$2.5 billion OFS. Always verify current prices directly with platform as unlisted prices change frequently.
Q6. What happened to HDB Financial unlisted shares?
HDB Financial Services was one of the most widely held unlisted shares in India, trading at ~₹1,250 in the unlisted market before its IPO. The IPO was priced at ₹740 -a 40% discount to unlisted market price -and listed at ₹835 (still 33% below unlisted purchase price for peak buyers). As of early 2026, the stock trades around ₹652–₹765. This is the key lesson about the gap between unlisted market sentiment and actual IPO/fundamental valuation.
Q7. What is the minimum investment for unlisted shares in India?
Minimum investment varies by company and platform -typically ₹25,000–₹50,000 on average, though this varies significantly. NSE and NSDL shares are relatively expensive per unit; companies like Zepto and OYO are lower per share but still require minimum lot sizes. Always confirm the specific minimum with your chosen platform before investing.
Disclaimer
This article is for informational and educational purposes only and does not constitute investment advice. Unlisted share prices change frequently and may differ between platforms. Investing in unlisted shares involves significant risks including illiquidity, valuation uncertainty, IPO timeline risk, and potential capital loss. Past performance of unlisted companies is not indicative of future results. Please conduct thorough due diligence and consult a SEBI-registered investment advisor before investing in unlisted shares.